CNBX (CNBX Pharmaceuticals) Other Stockholders Equity : $0.00 Mil (As of Feb. 2025)

View and export this data going back to 2007. Start your Free Trial

What is CNBX Pharmaceuticals Other Stockholders Equity?

CNBX Pharmaceuticals's Other Stockholders Equity for the quarter that ended in Feb. 2025 was $0.00 Mil.

CNBX Pharmaceuticals's quarterly Other Stockholders Equity increased from Aug. 2024 ($0.00 Mil) to Nov. 2024 ($0.00 Mil) and increased from Nov. 2024 ($0.00 Mil) to Feb. 2025 ($0.00 Mil).

CNBX Pharmaceuticals's annual Other Stockholders Equity declined from Aug. 2022 ($3.46 Mil) to Aug. 2023 ($0.00 Mil) and declined from Aug. 2023 ($0.00 Mil) to Aug. 2024 ($0.00 Mil).

CNBX Pharmaceuticals Other Stockholders Equity Historical Data

The historical data trend for CNBX Pharmaceuticals's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CNBX Pharmaceuticals Other Stockholders Equity Chart

CNBX Pharmaceuticals Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Other Stockholders Equity

Get a 7-Day Free Trial

2.78

3.46

CNBX Pharmaceuticals Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Other Stockholders Equity	Get a 7-Day Free Trial															-	-	-	-	-

CNBX Pharmaceuticals Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

CNBX Pharmaceuticals Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of CNBX Pharmaceuticals's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

CNBX Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CNBX Pharmaceuticals Inc (OTCPK:CNBX) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814

Website

https://www.cnbxpharma.com

CNBX Pharmaceuticals Inc is a clinical-stage biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. The firm's main product is the Cannabics SR, an oral capsule developed for the treatment of patients with cancer and cancer anorexia cachexia syndrome (CACS). It also has an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC) named RCC-33.

Executives

Cannabics Inc.	10 percent owner	108 WEST 13TH ST., WILMINGTON DE 19801
Thomas E Mills	director, officer: President, CEO, CFO
North American Mining Corp	10 percent owner	6767 WEST TROPICANA AVENUE, SUITE 229, LAS VEGAS NV 89103
Lou Hilford	director, officer: Vice-President, Secretary